Back to Search Start Over

MDC1 maintains active elongation complexes of RNA polymerase II

Authors :
European Commission
Danish Cancer Society Research Center
Danish Council for Independent Research
Lundbeck Foundation
Novo Nordisk Foundation
Swedish Research Council
Danish National Research Foundation
Japan Society for the Promotion of Science
Independent Research Fund Denmark
Pappas, George
Munk, Sebastian Howen Nesgaard
Watanabe, Kenji
Thomas, Quentin
Gál, Zita
Gram, Helena Hagner
Lee, MyungHee
Gómez-Cabello, Daniel
Kanellis, Dimitris C.
Olivares-Chauvet, Pedro
Larsen, Dorthe Helena
Gregersen, Lea Haarup
Maya-Mendoza, Apolinar
Galanos, Panagiotis
Bartek, Jiri
European Commission
Danish Cancer Society Research Center
Danish Council for Independent Research
Lundbeck Foundation
Novo Nordisk Foundation
Swedish Research Council
Danish National Research Foundation
Japan Society for the Promotion of Science
Independent Research Fund Denmark
Pappas, George
Munk, Sebastian Howen Nesgaard
Watanabe, Kenji
Thomas, Quentin
Gál, Zita
Gram, Helena Hagner
Lee, MyungHee
Gómez-Cabello, Daniel
Kanellis, Dimitris C.
Olivares-Chauvet, Pedro
Larsen, Dorthe Helena
Gregersen, Lea Haarup
Maya-Mendoza, Apolinar
Galanos, Panagiotis
Bartek, Jiri
Publication Year :
2023

Abstract

The role of MDC1 in the DNA damage response has been extensively studied; however, its impact on other cellular processes is not well understood. Here, we describe the role of MDC1 in transcription as a regulator of RNA polymerase II (RNAPII). Depletion of MDC1 causes a genome-wide reduction in the abundance of actively engaged RNAPII elongation complexes throughout the gene body of protein-encoding genes under unperturbed conditions. Decreased engaged RNAPII subsequently alters the assembly of the spliceosome complex on chromatin, leading to changes in pre-mRNA splicing. Mechanistically, the S/TQ domain of MDC1 modulates RNAPII-mediated transcription. Upon genotoxic stress, MDC1 promotes the abundance of engaged RNAPII complexes at DNA breaks, thereby stimulating nascent transcription at the damaged sites. Of clinical relevance, cancer cells lacking MDC1 display hypersensitivity to RNAPII inhibitors. Overall, we unveil a role of MDC1 in RNAPII-mediated transcription with potential implications for cancer treatment.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1431965630
Document Type :
Electronic Resource